Answers are grounded in this paper and cite their sources.
Myasthenia gravis may be a manifestation of chronic graft-versus-host disease in post-hematopoietic stem cell transplant (HSCT) setting and myasthenic crisis may be the initial presentation of the disease. As it presents with respiratory failure, it can contribute to significant morbidity and mortality in HSCT recipients. We report the first case in the literature of myasthenic crisis presenting as locked-in syndrome in a pediatric HSCT recipient. We describe a 7-year-old girl from South India with inherited bone marrow failure syndrome (ANKRD26 mutation) who developed chronic graft-versus-host disease (GVHD) following matched unrelated donor hematopoietic stem cell transplantation (HSCT). She presented with respiratory failure requiring mechanical ventilation and subsequently developed a locked-in-like state—complete absence of voluntary movement and verbal response with preserved pupillary reflexes. Retrospective history of ptosis, repetitive nerve stimulation demonstrating a decremental response, and strongly positive anti-acetylcholine receptor antibodies confirmed myasthenic crisis. Treatment with intravenous immunoglobulin and neostigmine resulted in full neurological recovery with successful extubation by day 10. This is the first reported case of post-HSCT myasthenic crisis presenting as locked-in-like syndrome. Clinicians must maintain vigilance for neuromuscular junction disorders in HSCT recipients, as early recognition is essential for timely treatment and favorable outcome.
No takes yet. Share an insight, caveat, or question.
Menon et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: